AI tutors aim to boost clinical trial enrollment in blood cancer patients
NCT ID NCT07305337
First seen Jan 05, 2026 · Last updated Apr 29, 2026 · Updated 17 times
Summary
This study tests whether an AI-powered chatbot can help people with blood cancers (like leukemia, lymphoma, or multiple myeloma) better understand clinical trials and feel more willing to join one. About 196 patients will be split into two groups: one gets standard education, the other gets chatbot-assisted education. The goal is to see if AI can make trial information clearer and easier to act on.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhongnan Hospital of Wuhan University
RECRUITINGWuhan, Hubei, 430071, China
Conditions
Explore the condition pages connected to this study.